Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 11-jild 3-son (2026)
RETROSPECTIVE ANALYSIS OF THE INHIBITOR FORM OF HEMOPHILIA A IN CHILDREN
МАХМУДОВА Дилором Салахитдиновна, ШАДИБЕКОВА Оксана Брониславовна, АЛМЕДОВА Наргиза Нигмаджановна, ДЕХКАНОВ Саттор Кахрамонович, МУСТАФАЕВ Арсений Русланович
Annotatsiya
Baseline factor VIII activity level cannot serve as a reliable clinical predictor of inhibitor development. Given the high frequency of this complication, regular laboratory screening for antibodies is justified for all patients receiving replacement therapy, regardless of the severity of the disease phenotype.
гемофилия А, ингибиторная форма, фактор VIII, Bethesda, титр ингибиторных антителhemophilia A, inhibitor form, factor VIII, Bethesda units, inhibitor antibody titergemofiliya A, ingibitor shakli, VIII omil, Bethesda, ingibitor antitanalar titri
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.